All posts by: Michael Zand

About Michael Zand

European Commission Approves VELCADE® as a Frontline Induction Therapy … – EON: Enhanced Online News (press release)

European Commission Approves VELCADE® as a Frontline Induction Therapy …EON: Enhanced Online News (press release)Until now, VELCADE's (bortezomib) indication has been limited to its use, in combination with melphalan and prednisone, in adult patients with multiple myeloma that are previously untreated and ineligible for stem cell transplant, and as a single agent … …read more   &nbs… Continue reading

2013-08-08 NEWS

Scientists identify biomarker to predict immune response risk after stem cell … – Medical Xpress

Scientists identify biomarker to predict immune response risk after stem cell …Medical XpressGraft-versus-host disease occurs when immune cells from the transplant see the patient's body as foreign and attack it. Approximately 20,000 allogeneic stem cell transplants were performed worldwide in 2012. Thirty to 40 percent of stem cell transplant … …read more   &nbs… Continue reading

2013-08-07 NEWS

Stem cells heal hearts – WWSB ABC 7

Stem cells heal heartsWWSB ABC 7MINNEAPOLIS, Minn. (Ivanhoe Newswire) — About 5.8 million Americans have heart failure, a condition that occurs when the heart can no longer pump enough blood to meet the body's needs. Now, researchers say a special type of stem cell may be the key … …read more   &nbs… Continue reading

2013-08-07 NEWS

Long-Term Results Continue To Show Non-Myeloablative Donor Stem Cell … – The MDS Beacon

Long-Term Results Continue To Show Non-Myeloablative Donor Stem Cell …The MDS BeaconCurrently, the only potential cure for MDS is donor (allogeneic) stem cell transplantation. During the procedure, the patient receives preparative chemotherapy and/or radiation treatment, which destroy their diseased cells as well as their healthy … …read more   &nbs… Continue reading

2013-08-07 NEWS